AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25349313 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 103
Study 25349313 — intervention group
Group type: COMPARATOR
Intervention: Thoracoscopy
Number of subjects: 103
Study 22727177 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose fluocinolone acetonide insert (0.2 μg/d)
Number of subjects: 953
Study 22727177 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose fluocinolone acetonide insert (0.5 μg/d)
Number of subjects: 953
Study 22727177 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 953
Study 20214164 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional ciprofloxacin (0.2%)
Number of subjects: 38
Study 20214164 — intervention group
Group type: COMPARATOR
Intervention: Intralesional sodium chloride hypertonic solution (7%)
Number of subjects: 38
Study 18056618 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark chocolate
Number of subjects: 0
Study 18056618 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk chocolate
Number of subjects: 0
Study 18056618 — intervention group
Group type: COMPARATOR
Intervention: Normal chocolate
Number of subjects: 0
Study 18056618 — intervention group
Group type: COMPARATOR
Intervention: No additional chocolate
Number of subjects: 0
Study 16283906 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulfate (SLS) at concentrations of 0.025% to 0.075%
Number of subjects: 7
Study 16283906 — intervention group
Group type: COMPARATOR
Intervention: Distilled water, acetone, and an empty chamber (controls)
Number of subjects: 7
Study 11882257 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-Based Medicine (EBM)
Number of subjects: 0
Study 11882257 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 10530579 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (CAE) 30 mg/kg/day in two divided doses for 5 days
Number of subjects: 716
Study 10530579 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (A/CA-10) 40 mg/kg/day in three divided doses for 10 days
Number of subjects: 716
Study 10530579 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate (A/CA-8) 80 mg/kg/day in three divided doses for 8 days
Number of subjects: 716
Study 7722188 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented soy product (112 g tempeh)
Number of subjects: 17
Study 7722188 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfermented soy (125 g soybean pieces)
Number of subjects: 17
Study 7722188 — intervention group
Group type: EXPERIMENTAL
Intervention: Tempeh diet
Number of subjects: 17
Study 7722188 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy diet (combined fermented and unfermented)
Number of subjects: 17
Study 1336212 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (100 mcg/kg i.v. and maintenance of 2-3 mcg/kg/min)
Number of subjects: 30
Study 1336212 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilation with N2O:O2 (1:1)
Number of subjects: 30
Study 1336212 — intervention group
Group type: COMPARATOR
Intervention: Naloxone (0.2-0.4 mg) administered after surgery
Number of subjects: 30
Study 6231418 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin administration
Number of subjects: 5
Study 6231418 — intervention group
Group type: COMPARATOR
Intervention: Oxytetracycline (2 X 500 mg/day for 5 days)
Number of subjects: 5
Study 6231418 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin for 6 days
Number of subjects: 5
Study 6231418 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline and trimethoprim administration
Number of subjects: 5
Study 6231418 — intervention group
Group type: COMPARATOR
Intervention: Antimicrobial drugs
Number of subjects: 5
Study 6231418 — intervention group
Group type: COMPARATOR
Intervention: Antimicrobial agents
Number of subjects: 5
Study 31221014 — intervention group
Group type: EXPERIMENTAL
Intervention: CBM instructional approaches (three different approaches)
Number of subjects: 164
Study 31221014 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 164
Study 30157917 — intervention group
Group type: EXPERIMENTAL
Intervention: ARRISA intervention (training staff, flagging records, motivational reminders)
Number of subjects: 10000
Study 30157917 — intervention group
Group type: EXPERIMENTAL
Intervention: ARRISA intervention
Number of subjects: 10000
Study 30157917 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 10000
Study 26866874 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily transcranial direct current stimulation (tDCS) targeting left frontal and temporo-parietal areas for five days
Number of subjects: 26
Study 26866874 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 26
Study 25322885 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 0
Study 25322885 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 0
Study 25322885 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-only version of CPT (CPT-C)
Number of subjects: 0
Study 25322885 — intervention group
Group type: EXPERIMENTAL
Intervention: Both forms of CPT
Number of subjects: 0
Study 22806212 — intervention group
Group type: EXPERIMENTAL
Intervention: Memantine (16-week treatment)
Number of subjects: 40
Study 22806212 — intervention group
Group type: COMPARATOR
Intervention: Placebo (16-week treatment)
Number of subjects: 40
Study 20699429 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week proprioceptive training program
Number of subjects: 522
Study 20699429 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 522
Study 17660728 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 Diabetes (T1D)
Number of subjects: 69
Study 17660728 — intervention group
Group type: EXPERIMENTAL
Intervention: Newly diagnosed T1D
Number of subjects: 69
Study 17660728 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-standing T1D
Number of subjects: 69
Study 17660728 — intervention group
Group type: EXPERIMENTAL
Intervention: T1D patients
Number of subjects: 69
Study 17660728 — intervention group
Group type: EXPERIMENTAL
Intervention: T1D
Number of subjects: 69
Study 15576392 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramural fibroids group
Number of subjects: 100
Study 15576392 — intervention group
Group type: COMPARATOR
Intervention: Control group (without fibroids)
Number of subjects: 100
Study 12200770 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol/150 microg levonorgestrel (EE/LNG)
Number of subjects: 16
Study 12200770 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microg ethinylestradiol/75 microg gestodene (EE/GSD)
Number of subjects: 16
Study 12200770 — intervention group
Group type: COMPARATOR
Intervention: Both EE/LNG and EE/GSD
Number of subjects: 16
Study 10885861 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pharmacological interventions
Number of subjects: 0
Study 10885861 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmes training and supporting self-care skills, mobility, continence, orientation and participation in activities
Number of subjects: 0
Study 10885861 — intervention group
Group type: EXPERIMENTAL
Intervention: Research evidence
Number of subjects: 0
Study 10885861 — intervention group
Group type: EXPERIMENTAL
Intervention: Methods of measuring well-being
Number of subjects: 0
Study 7750308 — intervention group
Group type: EXPERIMENTAL
Intervention: Music (M)
Number of subjects: 36
Study 7750308 — intervention group
Group type: COMPARATOR
Intervention: Silence (SIL)
Number of subjects: 36
Study 7750308 — intervention group
Group type: COMPARATOR
Intervention: Grey Noise (GN)
Number of subjects: 36
Study 2405141 — intervention group
Group type: EXPERIMENTAL
Intervention: Human surfactant derived from amniotic fluid, administered within 12 hours of birth, with a second dose if needed.
Number of subjects: 59
Study 2405141 — intervention group
Group type: EXPERIMENTAL
Intervention: Human surfactant treatment
Number of subjects: 59
Study 2405141 — intervention group
Group type: EXPERIMENTAL
Intervention: Retreatment with surfactant
Number of subjects: 59
Study 7138738 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol + codeine phosphate (400 mg + 30 mg)
Number of subjects: 24
Study 7138738 — intervention group
Group type: COMPARATOR
Intervention: Plain paracetamol (400 mg)
Number of subjects: 24
Study 7138738 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (400 mg)
Number of subjects: 24
Study 30696408 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartMoms® intervention (n = 37)
Number of subjects: 54
Study 30696408 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (n = 17)
Number of subjects: 54
Study 30696408 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartMoms® intervention and Usual Care
Number of subjects: 54
Study 30696408 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher gestational weight gain
Number of subjects: 54
Study 29303905 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-controlled inverse ratio ventilation (PC-IRV)
Number of subjects: 20
Study 29303905 — intervention group
Group type: COMPARATOR
Intervention: Volume control ventilation (VCV)
Number of subjects: 20
Study 29303905 — intervention group
Group type: COMPARATOR
Intervention: Pressure control ventilation (PCV)
Number of subjects: 20
Study 27535171 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (n = 29)
Number of subjects: 58
Study 27535171 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n = 29)
Number of subjects: 58
Study 25164908 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental arm (customized therapy based on BRCA1/RAP80 expression)
Number of subjects: 403
Study 25164908 — intervention group
Group type: COMPARATOR
Intervention: Control arm (docetaxel/cisplatin)
Number of subjects: 403
Study 22662606 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic paraumbilical hernioplasty (GL)
Number of subjects: 40
Study 22662606 — intervention group
Group type: COMPARATOR
Intervention: Conventional (open) umbilical hernioplasty (GO)
Number of subjects: 40
Study 18712389 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 26
Study 18712389 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality assessment of randomized controlled trials (RCTs)
Number of subjects: 26
Study 18712389 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of report and design
Number of subjects: 26
Study 18712389 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical significance in quality differentiation
Number of subjects: 26
Study 18712389 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of recommendation for adjuvant chemotherapy
Number of subjects: 26
Study 17599778 — intervention group
Group type: EXPERIMENTAL
Intervention: Endonasal laser dacryocystorhinostomy
Number of subjects: 126
Study 17599778 — intervention group
Group type: COMPARATOR
Intervention: Endonasal surgical dacryocystorhinostomy
Number of subjects: 126
Study 15167520 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc‐dextran joint scintigraphy
Number of subjects: 27
Study 11600473 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Papillary Balloon Dilation (EPBD)
Number of subjects: 235
Study 11600473 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic Sphincterotomy (EST)
Number of subjects: 235
Study 9702294 — intervention group
Group type: COMPARATOR
Intervention: Normal conditions (baseline)
Number of subjects: 0
Study 9702294 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenomas or adenocarcinomas
Number of subjects: 0
Study 8051620 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive immunotherapy with HIV-1 neutralizing monoclonal antibodies
Number of subjects: 11
Study 2497984 — intervention group
Group type: EXPERIMENTAL
Intervention: Cafergot P-B
Number of subjects: 254
Study 2497984 — intervention group
Group type: COMPARATOR
Intervention: Cafergot
Number of subjects: 254
Study 31152560 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based ultrasound training focusing on fetal weight scans
Number of subjects: 70
Study 31152560 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 70
Study 30741965 — intervention group
Group type: EXPERIMENTAL
Intervention: Twirled noise over a unitary 2t-design for quantum circuits
Number of subjects: 0
Study 30741965 — intervention group
Group type: EXPERIMENTAL
Intervention: Local random circuits for twirling separable noisy channel over the Clifford group
Number of subjects: 0
Study 30741965 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic noise estimation via average fidelity
Number of subjects: 0
Study 28141662 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week dance-based aquatic exercise program
Number of subjects: 34
Study 25183667 — intervention group
Group type: COMPARATOR
Intervention: Immersible ergocycle (Hydrorider®)
Number of subjects: 20
Study 25183667 — intervention group
Group type: EXPERIMENTAL
Intervention: Dryland ergocycle (Ergoline 800S)
Number of subjects: 20
Study 24278914 — intervention group
Group type: EXPERIMENTAL
Intervention: One-piece implants
Number of subjects: 20
Study 24278914 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-part implants
Number of subjects: 20
Study 21679106 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard platelet transfusion
Number of subjects: 0
Study 21679106 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow platelet transfusion
Number of subjects: 0
Study 19839993 — intervention group
Group type: EXPERIMENTAL
Intervention: Asenapine (10 mg BID on day 1; 5 or 10 mg BID thereafter; mean daily dosage 18.2 mg)
Number of subjects: 488
Study 19839993 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (15 mg BID on day 1; 5-20 mg QD thereafter; mean daily dosage 15.8 mg)
Number of subjects: 488
Study 19839993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 488
Study 16981102 — intervention group
Group type: EXPERIMENTAL
Intervention: AFE-guided biopsy plus four-quadrant biopsies
Number of subjects: 187
Study 16981102 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic surveillance with four-quadrant biopsies
Number of subjects: 187
Study 16981102 — intervention group
Group type: EXPERIMENTAL
Intervention: AFE in study phase 2
Number of subjects: 187
Study 16981102 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopy in study phase 2
Number of subjects: 187
Study 14719427 — intervention group
Group type: EXPERIMENTAL
Intervention: VAMP Plus system (blood conservation device)
Number of subjects: 160
Study 14719427 — intervention group
Group type: COMPARATOR
Intervention: Standard arterial pressure line set (control group)
Number of subjects: 160
Study 10913502 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium (administered for 4 weeks)
Number of subjects: 21
Study 9299654 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (5 mg)
Number of subjects: 687
Study 9299654 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine retard (120 mg)
Number of subjects: 687
Study 9299654 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cetirizine (5 mg) and pseudoephedrine retard (120 mg)
Number of subjects: 687
Study 9299654 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cetirizine and pseudoephedrine
Number of subjects: 687
Study 8143888 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin, Ofloxacin, Enoxacin, Ciprofloxacin, Lomefloxacin (200 mg three times daily for 3 consecutive days)
Number of subjects: 180
Study 2872516 — intervention group
Group type: EXPERIMENTAL
Intervention: Total lymphoid irradiation (TLI; 1980 cGy)
Number of subjects: 40
Study 2872516 — intervention group
Group type: COMPARATOR
Intervention: Sham irradiation
Number of subjects: 40
Study 28966335 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-Eluting Stents (EES)
Number of subjects: 1443
Study 28966335 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-Eluting Stents (SES)
Number of subjects: 1443
Study 26926020 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid maxillary expansion (RME)
Number of subjects: 33
Study 26926020 — intervention group
Group type: COMPARATOR
Intervention: Control group (no orthodontic treatment)
Number of subjects: 33
Study 26926020 — intervention group
Group type: COMPARATOR
Intervention: Comparison between RME and control groups
Number of subjects: 33
Study 24742255 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (30 minutes twice weekly for 6 weeks)
Number of subjects: 36
Study 24742255 — intervention group
Group type: COMPARATOR
Intervention: Nonmassage touch/holding sham treatment (30 minutes twice weekly for 6 weeks)
Number of subjects: 36
Study 22453648 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtherapeutic CPAP for 2 weeks
Number of subjects: 41
Study 22453648 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic CPAP for 2 weeks
Number of subjects: 41
Study 20085542 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) guidance
Number of subjects: 110
Study 20085542 — intervention group
Group type: COMPARATOR
Intervention: Neurostimulation (NS) and ultrasound (NSUS) guidance
Number of subjects: 110
Study 18727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 0
Study 18727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal Standard (Oxytetracycline)
Number of subjects: 0
Study 18727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid chromatographic/tandem mass spectrometric method
Number of subjects: 0
Study 18727530 — intervention group
Group type: EXPERIMENTAL
Intervention: Method validation parameters
Number of subjects: 0
Study 15972906 — intervention group
Group type: EXPERIMENTAL
Intervention: Valgus corrective brace
Number of subjects: 12
Study 15972906 — intervention group
Group type: COMPARATOR
Intervention: Simple hinged brace
Number of subjects: 12
Study 12204348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 0
Study 12204348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10470326 — intervention group
Group type: EXPERIMENTAL
Intervention: Antagonists to inflammatory cytokines IL-1 and TNF
Number of subjects: 0
Study 10470326 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 8916311 — intervention group
Group type: EXPERIMENTAL
Intervention: Idarubicin (IDA) plus cytarabine (Ara-C)
Number of subjects: 32
Study 8916311 — intervention group
Group type: COMPARATOR
Intervention: Daunorubicin (DNR) plus cytarabine (Ara-C)
Number of subjects: 32
Study 1919952 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow's milk
Number of subjects: 73
Study 1919952 — intervention group
Group type: COMPARATOR
Intervention: Chicken-based formula
Number of subjects: 73
Study 6805713 — intervention group
Group type: EXPERIMENTAL
Intervention: After-exercise thermography
Number of subjects: 112
Study 6805713 — intervention group
Group type: COMPARATOR
Intervention: Fibrinogen-uptake test
Number of subjects: 112
Study 31618539 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (laparoscopic Nissen fundoplication)
Number of subjects: 78
Study 31618539 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medical treatment (omeprazole plus baclofen, with desipramine added depending on symptoms)
Number of subjects: 78
Study 31618539 — intervention group
Group type: COMPARATOR
Intervention: Control medical treatment (omeprazole plus placebo)
Number of subjects: 78
Study 31618539 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medical treatment
Number of subjects: 78
Study 27818283 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored video intervention with newsletters (5 during and 3 after pregnancy) and videos (3 during and 2 after pregnancy)
Number of subjects: 0
Study 27818283 — intervention group
Group type: COMPARATOR
Intervention: Usual care approaches (newsletters and videos on healthy pregnancy topics)
Number of subjects: 0
Study 24820653 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alendronate (ALN)
Number of subjects: 299
Study 24820653 — intervention group
Group type: COMPARATOR
Intervention: Not receiving oral alendronate (Control)
Number of subjects: 299
Study 23746015 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergent surgical reduction and fixation
Number of subjects: 36
Study 23746015 — intervention group
Group type: COMPARATOR
Intervention: Secondary operative fixation after emergent closed reduction
Number of subjects: 36
Study 21930149 — intervention group
Group type: EXPERIMENTAL
Intervention: GSM mobile phone RF exposure for 15 minutes
Number of subjects: 26
Study 21930149 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure for 15 minutes
Number of subjects: 26
Study 18947980 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule of olive leaf extract
Number of subjects: 45
Study 18947980 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid extract of olive leaf
Number of subjects: 45
Study 18947980 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 45
Study 17909140 — intervention group
Group type: EXPERIMENTAL
Intervention: Block play intervention (distribution of 2 sets of building blocks)
Number of subjects: 175
Study 17909140 — intervention group
Group type: COMPARATOR
Intervention: Control group (no block play)
Number of subjects: 175
Study 17909140 — intervention group
Group type: EXPERIMENTAL
Intervention: Block play intervention
Number of subjects: 175
Study 17909140 — intervention group
Group type: COMPARATOR
Intervention: Hyperactivity scores
Number of subjects: 175
Study 15177817 — intervention group
Group type: EXPERIMENTAL
Intervention: Lexical decision task performance in aphasic patients
Number of subjects: 0
Study 15177817 — intervention group
Group type: COMPARATOR
Intervention: Lexical decision task performance in normal readers
Number of subjects: 0
Study 12452733 — intervention group
Group type: EXPERIMENTAL
Intervention: Ionic low-osmolar contrast media (LOCM)
Number of subjects: 0
Study 12452733 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ionic iso-osmolar contrast media (IOCM)
Number of subjects: 0
Study 12452733 — intervention group
Group type: COMPARATOR
Intervention: Ionic high-osmolar contrast media (HOCM)
Number of subjects: 0
Study 12452733 — intervention group
Group type: COMPARATOR
Intervention: Non-ionic low-osmolar contrast media (LOCM)
Number of subjects: 0
Study 9806313 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy density (LED) diet (373 kJ/100 g)
Number of subjects: 6